Cybin Inc. (Cboe CA: CYBN) (NYSE American: CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage ...
TipRanks on MSN
Cybin to Release Q2 Financial Results and Business Update
An update from Cybin ( ($TSE:CYBN) ) is now available. Cybin Inc. announced it will release its second quarter financial results and provide a ...
The latest announcement is out from Cybin ( (TSE:CYBN) ).
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through ...
- Combination creates the largest intellectual property portfolio in the psychedelic drug development sector with 28 patents granted and 158 patents pending - - Creates strong synergies by combining ...
TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...
Positive Clinical Progress: Cybin Inc. has reported significant advancements in its clinical programs, notably achieving a primary efficacy endpoint in its Phase 2 study of CYB003 for treating Major ...
Visit a quote page and your recently viewed tickers will be displayed here. Eric So is the founder of Globalive Technology Partners, Inc. (founded in 2017), Cybin, Inc. (founded in 2016), and Cybin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback